BCM
TMO icon

Bluefin Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Bluefin Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10,800
Closed -$23K – 734
2019
Q3 		$23K Buy
+10,800
New +$3.09M ﹤0.01% 427
2014
Q2 		– Sell
-625
Closed -$200K – 788
2014
Q1 		$200K Buy
+625
New +$74.3K 0.01% 436

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bluefin Capital Management's TMO Position: Q1 2020 in Review

Bluefin Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2020, closing a stake of 10,604 shares — an estimated $3.44M sold.

Bluefin Capital Management first reported a position in TMO in Q1 2014 and held it in 5 quarters. The position peaked at $5.3M in Q1 2014. 1,674 funds tracked by Wall St. Rank hold TMO as of Q1 2020.

  • Bluefin Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2020 after selling out during the quarter.
  • Bluefin Capital Management sold 10,604 Thermo Fisher Scientific shares in Q1 2020, an estimated $3.44M.
  • Bluefin Capital Management first reported a position in Thermo Fisher Scientific in Q1 2014 and held it in 5 quarters.
  • Bluefin Capital Management's Thermo Fisher Scientific position peaked at $5.3M in Q1 2014.
  • 1,674 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2020.

Based on Bluefin Capital Management's 13F filing for Q1 2020, filed 15 May 2020.